Top Ten Equity Holdings and Exposures

Summary by AI BETAClose X

Polar Capital Global Healthcare Trust reports that as at 30 October 2026 its top ten equity holdings total 55.5% of the portfolio, led by Eli Lilly 10.8% and Johnson & Johnson 9.6%, with UnitedHealth 5.9% and AstraZeneca 5.2%; sector exposures are concentrated in Pharmaceuticals 38.1% and Biotechnology 24.4% (Healthcare Equipment 15.6%); geographic exposure is 75.8% United States and Cash is reported as -8.7%, implying net gearing that could amplify volatility and affect share price sensitivity to US healthcare and large-cap pharma moves.

Disclaimer*

UK 100

Latest directors dealings